Unknown

Dataset Information

0

Human Immunodeficiency Virus Type 1 and Tuberculosis Coinfection in Multinational, Resource-limited Settings: Increased Neurological Dysfunction.


ABSTRACT: BACKGROUND:AIDS Clinical Trial Group 5199 compared neurological and neuropsychological test performance of human immunodeficiency virus type 1 (HIV-1)-infected participants in resource-limited settings treated with 3 World Health Organization-recommended antiretroviral (ART) regimens. We investigated the impact of tuberculosis (TB) on neurological and neuropsychological outcomes. METHODS:Standardized neurological and neuropsychological examinations were administered every 24 weeks. Generalized estimating equation models assessed the association between TB and neurological/neuropsychological performance. RESULTS:Characteristics of the 860 participants at baseline were as follows: 53% female, 49% African; median age, 34 years; CD4 count, 173 cells/?L; and plasma HIV-1 RNA, 5.0 log copies/mL. At baseline, there were 36 cases of pulmonary, 9 cases of extrapulmonary, and 1 case of central nervous system (CNS) TB. Over the 192 weeks of follow-up, there were 55 observations of pulmonary TB in 52 persons, 26 observations of extrapulmonary TB in 25 persons, and 3 observations of CNS TB in 2 persons. Prevalence of TB decreased with ART initiation and follow-up. Those with TB coinfection had significantly poorer performance on grooved pegboard (P < .001) and fingertapping nondominant hand (P < .01). TB was associated with diffuse CNS disease (P < .05). Furthermore, those with TB had 9.27 times (P < .001) higher odds of reporting decreased quality of life, and had 8.02 times (P = .0005) higher odds of loss of productivity. CONCLUSIONS:TB coinfection was associated with poorer neuropsychological functioning, particularly the fine motor skills, and had a substantial impact on functional ability and quality of life. CLINICAL TRIALS REGISTRATION:NCT00096824.

SUBMITTER: Robertson KR 

PROVIDER: S-EPMC6495021 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Human Immunodeficiency Virus Type 1 and Tuberculosis Coinfection in Multinational, Resource-limited Settings: Increased Neurological Dysfunction.

Robertson Kevin R KR   Oladeji Bibilola B   Jiang Hongyu H   Kumwenda Johnstone J   Supparatpinyo Khuanchai K   Campbell Thomas B TB   Hakim James J   Tripathy Srikanth S   Hosseinipour Mina C MC   Marra Christina M CM   Kumarasamy Nagalingeswaran N   Evans Scott S   Vecchio Alyssa A   La Rosa Alberto A   Santos Breno B   Silva Marcus T MT   Montano Sylvia S   Kanyama Cecilia C   Firnhaber Cindy C   Price Richard R   Marcus Cheryl C   Berzins Baida B   Masih Reena R   Lalloo Umesh U   Sanne Ian I   Yosief Sarah S   Walawander Ann A   Nair Aspara A   Sacktor Ned N   Hall Colin C  

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20190501 10


<h4>Background</h4>AIDS Clinical Trial Group 5199 compared neurological and neuropsychological test performance of human immunodeficiency virus type 1 (HIV-1)-infected participants in resource-limited settings treated with 3 World Health Organization-recommended antiretroviral (ART) regimens. We investigated the impact of tuberculosis (TB) on neurological and neuropsychological outcomes.<h4>Methods</h4>Standardized neurological and neuropsychological examinations were administered every 24 weeks  ...[more]

Similar Datasets

| S-EPMC3948456 | biostudies-literature
| S-EPMC5447887 | biostudies-other
| S-EPMC3248985 | biostudies-literature
| S-EPMC3809900 | biostudies-literature
| S-EPMC10964563 | biostudies-literature
| S-EPMC4220801 | biostudies-other
| S-EPMC6814773 | biostudies-literature
| S-EPMC4169284 | biostudies-literature
| S-EPMC3526495 | biostudies-literature
| S-EPMC3307996 | biostudies-literature